MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CGON
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

CG Oncology (CGON) Ownership - Who owns CG Oncology?

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
400 Spectrum Center Drive
Phone
+1 949 409-3700
Employees
142
Web
https://www.cgoncology.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.25B
P/E Ratio
N/A
Total Cash
1.08B
Projected Growth
N/A
Total Debt
7.58M
Revenue
5.07M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
12.20
Total Debt/Equity
N/A
Revenue/Share
0.06 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CGON
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for CGON
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
400 Spectrum Center Drive
Phone
+1 949 409-3700
Employees
142
Web
https://www.cgoncology.com